Hanshang Group Co., Ltd.

600774

CNE000000NC5

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
6.81 ^CNY	-1.16%		+2.41%	-30.93%

Apr. 25	Hanshang Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 25	Hanshang Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Tranche Update on Hanshang Group Co., Ltd.'s Equity Buyback Plan announced on May 25, 2022.

May 24, 2023

From April 1, 2023 to May 24, 2023, the company has repurchased 2,355,130 shares, representing 0.81% for CNY 30.48 million. With this, the company has completed the repurchase of 6,024,130 shares, representing 2.06% for CNY 75.48 million under the buyback announced on May 25, 2022.

Latest news about Hanshang Group Co., Ltd.

Hanshang Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Hanshang Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 25	CI
Meilleure Health Sells 661,408 Shares of Hanshang Group	Jan. 10	MT
Hanshang Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Hanshang Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
Hanshang Group Co., Ltd. agreed to acquire Zhen An Industrial Co., Ltd. from Zall International Commercial Management Wuhan Partnership Enterprise (Limited Partnership) and Zhen Property Limited.	23-08-22	CI
Hanshang Group Co., Ltd. announced a financing transaction	23-08-21	CI
Meilleure Health Further Disposes of Hanshang Shares for HK$7.1 Million	23-07-11	MT
Meilleure Health Sells 1.4 Million Shares in Hanshang Group	23-07-06	MT
Tranche Update on Hanshang Group Co., Ltd.'s Equity Buyback Plan announced on May 25, 2022.	23-05-24	CI
Hanshang Group Co., Ltd.'s Equity Buyback announced on May 25, 2022 has closed with 6,024,130 shares, representing 2.06% for CNY 75.48 million.	23-05-23	CI
Hanshang Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Hanshang Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-25	CI
Tranche Update on Hanshang Group Co., Ltd.'s Equity Buyback Plan announced on May 25, 2022.	23-03-31	CI
Hanshang Group Co., Ltd. agreed to acquire 81.34% stake in Wuhan Tongji Technology Group Co., Ltd.	23-01-10	CI
Hanshang Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Hanshang Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-30	CI
Tranche Update on Hanshang Group Co., Ltd.'s Equity Buyback Plan announced on May 25, 2022.	22-07-04	CI
Hanshang Group Co., Ltd. announces an Equity Buyback for CNY 150 million worth of its shares.	22-05-25	CI
Hanshang Group Co., Ltd. authorizes a Buyback Plan.	22-05-24	CI
Hanshang Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
Hanshang Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30	CI
Wuhan Hanshang Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI
Wuhan Hanshang Group Co.,Ltd. announced that it has received CNY 915.73518 million in funding from a group of investors	21-09-08	CI
Wuhan Hanshang Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-30	CI

Chart Hanshang Group Co., Ltd.

Duration

Period

More charts

Company Profile

Hanshang Group Co Ltd, formerly Wuhan Hanshang Group Co Ltd is a China-based company principally engaged in the retail of commodities. The Company is also engaged in the exhibition business, hotel business, tourism business and property management business. The Company mainly operates its retail business through department stores, shopping malls and specialty stores. The Company mainly operates 21st Century Shopping Mall, Ginza Mall and Wuzhan Shopping Center.

Sector

Pharmaceuticals

Calendar

2024-05-16 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
HANSHANG GROUP CO., LTD.	-30.93%	272M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B